Furthermore, tumor PCs increase the expression of CX43 in MSCs leading to an increased levels of CXCL12 and stimulation of its corresponding receptor expressed on MM cells (Fig. 7). The gene discussed is CXCL12; the disease is Miyoshi myopathy.